Most cases of cervical cancer are caused by the human papillomavirus. Our bodies can fight off most HPV infections; however, there are some types of the infection that are much ha ...

India has achieved an important milestone by successfully validating its first indigenous Human Papillomavirus (HPV) test for cervical cancer screening. The development is expected to make cervical ...

NEW DELHI: As India rolls out its national HPV vaccination campaign, researchers from AIIMS New Delhi, ICMR institutes and the WHO's International Agency for Research on Cancer (IARC), France, have ...

Cervical cancer remains an important public health problem in India, with approximately 127,000 new cases and 80,000 cervical cancer-related deaths reported annually. According to the release, the ...

Scientists at Mass General Brigham have created HPV-DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, ...

Dear Dr. Roach: I am a 61-year-old retired African-American woman. This past week, I just had a Pap smear (I hadn't had one since 2021) and was told that it was positive for human papillomavirus (HPV) ...

A vaccine long framed as protection against cervical cancer in women is now showing clear benefits for men. Boys and young men who received the human papilloma virus, or HPV, vaccine had about half ...

Dear Dr. Roach: I am a 35-year-old female. My doctor did a Pap smear and a human papilloma virus (HPV) test that was positive for one of the "risk types" (16, 18 and 45 according to my chart) — but ...

Making human papillomavirus (HPV) self-testing available to all women increases the number of people screened for cervical cancer, a new study led by researchers from Te Herenga Waka—Victoria ...

Research has increasingly shown that HPV testing is more effective than cytology at detecting cervical precancer. A cohort study showed that patients who tested HPV negative had the lowest cumulative ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #FDA--Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician ...